Skip to content


BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

  • Xing-dong Xu1,
  • Lan Yang1,
  • Li-yun Zheng2,
  • Yan-yan Pan3,
  • Zhi-fei Cao3,
  • Zhi-qing Zhang4,
  • Quan-sheng Zhou3,
  • Bo Yang1Email author and
  • Cong Cao4Email author
Contributed equally
BMC Cancer201414:373

Received: 26 July 2013

Accepted: 16 May 2014

Published: 27 May 2014

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting

Original Submission
26 Jul 2013 Submitted Original manuscript
18 Aug 2013 Reviewed Reviewer Report - Zhigang Bi
7 Feb 2014 Reviewed Reviewer Report - Giovanni Tesoriere
17 Feb 2014 Reviewed Reviewer Report - Nelson Yee
10 Apr 2014 Author responded Author comments - Bo Yang
Resubmission - Version 2
10 Apr 2014 Submitted Manuscript version 2
16 May 2014 Editorially accepted
27 May 2014 Article published 10.1186/1471-2407-14-373

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting

You can find further information about the peer review system here.

Authors’ Affiliations

Department of General Surgery, the Third Hospital affiliated to Soochow University, Changzhou City, China
Department of Neurology, the First Affiliated Hospital of Soochow University, Suzhou, China
Cyrus Tang Hematology Center, Soochow University, Suzhou, China
Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Institute of Neuroscience, Soochow University, Suzhou, China